FDA 483 OBSERVATION · #171 OF 1,945 MOST-CITED

Complaint Handling Procedure

FDA cited this observation 186 times across 177 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs186
BY FISCAL YEAR
FY20264
FY202513
FY202421
FY20238
FY202213
FY202110
FY20205
FY201918
FY201825
FY201733
FY201636

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 4.3× the rate of the average FDA-cited firm (33.9% vs 7.8%), across 177 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

Procedures describing the handling of written and oral complaints related to drug products are deficiently written or followed.

Episciences Inc · Boise, Idaho · Drugs · 2026-07-31

Procedures describing the handling of written and oral complaints related to drug products are deficiently written or followed.

Samchundang Pharm Co., Ltd. · Hwaseong · Drugs · 2026-05-19

Procedures describing the handling of written and oral complaints related to drug products are not written or followed.

Emcure Pharmaceuticals Limited · Ahmedabad · Drugs · 2026-05-15

Procedures describing the handling of written and oral complaints related to drug products are deficiently written or followed.

LPNA Group Inc. · Tonawanda, New York · Drugs · 2026-01-21

Procedures describing the handling of written and oral complaints related to drug products are deficiently written or followed.

CosMedical Technologies, LLC · Davie, Florida · Drugs · 2025-07-07

Procedures describing the handling of written and oral complaints related to drug products are not written or followed and deficiently written or followed.

Avadim Holdings Inc · Swannanoa, North Carolina · Drugs · 2025-05-22

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Quality risk management →Pharmaceutical quality system →Pharma industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →